Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of recombinant human IGF-1 on nutritional status in liver cirrhosis (pilot study)
2012-001239-30Phase 4Active
- Sponsor
- Foundation for Liver Research
- Start
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mecasermin in Cirrhosis, sponsored by Foundation for Liver Research. Started Apr 2012; status: active.
02
Drugs
mecasermin
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2012-001239-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001239-30.